The present invention relates to a vaccine against malaria comprising a polypeptide having the amino acid sequence of the C-terminal part of the circumsporozoite protein of a Plasmodium species, in which polypeptide one or more pairs of cysteine residues are oxidized, and optionally a suitable carrier and/or adjuvant and/or biodegradable microcapsules for use in humans.
Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
National States: AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW ARIPO: GH GM KE LS MW SD SL SZ TZ UG ZW EAPO: AM AZ BY KG KZ MD RU TJ TM EPO: AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE OAPI: BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG